Healthcare - Biotechnology - NASDAQ - US
$ 6.86
-5.38 %
$ 143 M
Market Cap
-1.2
P/E
Price Target
Average
155.10%
Revenue Forecast
Estimate
51.37%
EBIT
Estimate
58.20%
Net Income
Estimate
22.39%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Adverum Biotechnologies, Inc.
Wall Street analysts predict an average 1-year price target for ADVM of $17.5 , with forecasts ranging from a low of $10 to a high of $28 .
ADVM Lowest Price Target
Wall Street Target
10 USD
45.77%
ADVM Average Price Target
Wall Street Target
17.5 USD
155.10%
ADVM Highest Price Target
Wall Street Target
28 USD
308.16%
REVENUE FORECAST
Revenue Forecast Chart ADVM
EBIT FORECAST
EBIT Forecast Chart ADVM
NET INCOME FORECAST
Net Income Chart ADVM